TLDR PumpFun saw over 1.3 million active addresses in August despite facing significant losses. The platform created 595,000 new tokens to regain its top position among Solana launchpads. Over 60% of traders ended the month with losses, totaling $66 million across the platform. Around 882,000 wallets lost between $0 and $1,000, accounting for more than [...] The post PumpFun Hits 1.3 Million Active Users, Suffers $66 Million in Losses appeared first on CoinCentral.TLDR PumpFun saw over 1.3 million active addresses in August despite facing significant losses. The platform created 595,000 new tokens to regain its top position among Solana launchpads. Over 60% of traders ended the month with losses, totaling $66 million across the platform. Around 882,000 wallets lost between $0 and $1,000, accounting for more than [...] The post PumpFun Hits 1.3 Million Active Users, Suffers $66 Million in Losses appeared first on CoinCentral.

PumpFun Hits 1.3 Million Active Users, Suffers $66 Million in Losses

TLDR

  • PumpFun saw over 1.3 million active addresses in August despite facing significant losses.
  • The platform created 595,000 new tokens to regain its top position among Solana launchpads.
  • Over 60% of traders ended the month with losses, totaling $66 million across the platform.
  • Around 882,000 wallets lost between $0 and $1,000, accounting for more than $64 million in losses.
  • PumpFun repurchased $58.7 million worth of PUMP tokens to stabilize the token’s price.

PumpFun saw over 1.3 million active addresses during August. Despite the high activity, users experienced a total loss of $66 million. This comes amid PumpFun‘s efforts to reclaim the top spot in the Solana launchpad market.

PumpFun Sees $66 Million Loss in August

In August, PumpFun created 595,000 new tokens, which helped the platform reclaim its position among Solana’s top launchpads. However, despite nearly 1.35 million addresses actively trading, profitability remained low.

Most traders saw losses, with over 60% finishing in the red. No trader earned more than $1 million in profit. According to crypto researcher Defioasis, the platform experienced heavy losses despite the high trading volume.

Around 65.4% of addresses, or roughly 882,000 wallets, lost between $0 and $1,000. The average loss per wallet was $73.41. Though individually small, this group accounted for over $64 million in total losses.

Approximately 416,000 addresses earned modest gains of up to $1,000. A smaller group of 18,000 traders made between $1,000 and $10,000. Only 1,665 addresses gained more than $10,000, leaving traders with a net loss of $66 million.

Platform’s Token Buyback and Market Share

PumpFun repurchased $58.7 million in PUMP tokens to stabilize the price, boosting the token’s value amid a volatile market. The platform has now repurchased over $66.6 million in total tokens, absorbing over 17.5 billion tokens at an average price of $0.003765.

Despite the challenges, PumpFun captured 46.6% of the Solana launchpad market share. Rival platform LetsBonk trailed with less than 9%. This strong market presence reflects the platform’s significant trading volume and user activity.

PumpFun now has more than 71,000 PUMP holders, many of whom are retail traders. Smaller wallets with fewer than 1,000 tokens control 46% of the total token distribution. This highlights growing grassroots involvement, despite the ongoing class-action lawsuit against the platform.

The lawsuit, filed earlier this year, claims that PumpFun operates like an “unlicensed casino.” It accuses the platform of rigging its token mechanics, leading to significant investor losses. As the legal battle continues, the platform remains a focal point in the crypto industry.

The post PumpFun Hits 1.3 Million Active Users, Suffers $66 Million in Losses appeared first on CoinCentral.

Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0.002216
$0.002216$0.002216
-4.85%
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23